Literature DB >> 6703683

High-pressure liquid chromatographic method for determination of Sch 28191 in biological fluids.

H Kim, C Lin.   

Abstract

A high-pressure liquid chromatographic method has been developed for the measurement of N-D-ornithyl amphotericin B methyl ester (Sch 28191) in biological fluid. The method involves protein precipitation with methanol, followed by separation of the supernatant on a reverse-phase column and quantitation by absorbance at 405 nm. This technique resulted in a recovery of 97%. There was a good linear relationship between the peak height ratio and Sch 28191 concentrations ranging from 0.015 to 20 micrograms/ml. In addition, this method was specific for Sch 28191 since all of its analogs tested did not interfere with the assay. The method was reproducible with a lower limit of quantitation of 0.015 microgram/ml. Serum levels obtained from this method were in good agreement with those obtained from a microbiological assay only when drug concentrations were higher than 1.5 microgram/ml. The high-pressure liquid chromatographic method is useful in monitoring serum and urine drug levels in animals and should prove to be useful for pharmacokinetic studies of the drug with therapeutic doses in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703683      PMCID: PMC185432          DOI: 10.1128/AAC.25.1.45

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Separation of polyene antifungal antibiotics by high-speed liquid chromatography.

Authors:  W Mechlinski; C P Schaffner
Journal:  J Chromatogr       Date:  1974-11-06

2.  An internally-standardized assay for amphotericin B in tissues and plasma.

Authors:  J W Mayhew; C Fiore; T Murray; M Barza
Journal:  J Chromatogr       Date:  1983-05-13

3.  Amphotericin B pharmacokinetics in humans.

Authors:  A J Atkinson; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

4.  Excretion pathways of amphotericin B.

Authors:  P C Craven; T M Ludden; D J Drutz; W Rogers; K A Haegele; H B Skrdlant
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

5.  Quantitation of amphotericin B with use of high-pressure liquid chromatography.

Authors:  I Nilsson-Ehle; T T Yoshikawa; J E Edwards; M C Schotz; L B Guze
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

  5 in total
  6 in total

1.  Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys.

Authors:  H Kim; D Loebenberg; A Marco; S Symchowicz; C Lin
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

2.  In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.

Authors:  G S Kobayashi; J R Little; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

3.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.

Authors:  J R Perfect; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Induction of amphotericin B-specific antibodies for use in immunoassays.

Authors:  J R Little; K D Little; E Plut; M Koldin; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard.

Authors:  G G Granich; G S Kobayashi; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.